The patients who will receive bronchoscopic examination with or without an obstructive lung disease, a restrictive lung disease, and/or hypoxemia.
Conditions
Interventions
HIGH FLOW THERAPY SYSTEM MAX Venturi Pacific Medico Co., Ltd.
Nasal Cannula
Sponsors
Kanazawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients age is more than 20 years old. 2. Patient to perform bronchoscopy, and having either obstructive lung disease, restrictive lung disease, and hypoxemia. 3. Patients with hospitalization or hospitalization after examination. 4. Patients with 5 L/min or less in nasal cannula therapy. 5. Informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with pneumothorax 2. The type 2 respiratory failure patient who needs respirator management. 3. The patient who has difficulty in oxygen dosage from a nose. 4. If the patient's written consent cannot be obtained. 5. Patients judged to be inappropriate for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Utility 1: Changes of SpO2 of the patients during bronchoscopy. 2: The rate of inspection discontinuation. 2) Safety 1: The period of bronchoscopic examination. 2: The percentage of pneumothorax, and necessary of mechanical ventilation. | — |
Countries
Japan
Contacts
Public ContactTaku Oikawa
Kanazawa Medical University Respiratory Medicine
Outcome results
None listed